Skip to main content
JGH Open: An Open Access Journal of Gastroenterology and Hepatology logoLink to JGH Open: An Open Access Journal of Gastroenterology and Hepatology
. 2023 Jan 27;7(2):152–156. doi: 10.1002/jgh3.12867

Gastroesophageal reflux disease incidence among male patients with irritable bowel syndrome: A single‐center cross‐sectional study in southern Iran

Fereshteh Gholamnezhad 1, Ahmad Qeisari 1, Reza Shahriarirad 2,3,
PMCID: PMC9958336  PMID: 36852149

Abstract

Background and Aim

Gastrointestinal reflux disease (GERD) and irritable bowel syndrome (IBS) are among the most common gastrointestinal disorders in which the overlap of these diseases and their syndromes has been frequently reported. In this study, we aimed to evaluate GERD incidence among IBS patients and the related risk factors.

Methods

Male patients aged 18–60 years with an impression of IBS and referred to the gastrointestinal clinic from March 2019 to 2020 in Shiraz, Iran, were included in this study.

Results

Among the 163 enrolled patients with an average age of 31.53 ± 9.38 years, 64 (39.3%) were diagnosed with GERD. Based on statistical analysis, there was a significant association between GERD and the IBS patients' age (P = 0.006), smoking (P = 0.011), and alcohol consumption (P = 0.043). Also, GERD among IBS patients was significantly associated with the type of IBS (P < 0.001), with IBS‐D having the lowest incidence (19.4%) and IBS‐M the highest incidence of GERD (66.7%). Based on multivariate analysis, smoking had a reverse and significant correlation with lower incidence of GERD (OR = −1.364; P = 0.002).

Conclusion

Our results demonstrate that among male IBS patients, younger age, smoking, and alcohol consumption were among the risk factors for GERD. These findings may provide further insight into the best approach to treating these diseases.

Keywords: gastrointestinal reflux disease, Iran, irritable bowel syndrome, male


GERD and IBS are among the most common gastrointestinal disorders in which the overlapping of these diseases and their syndromes has been frequently reported. Our results demonstrated that among male IBS patients, younger age, smoking, and alcohol were among the risk factors for GERD. Improvements and changes in the clinicians and scientists point of view regarding GERD and IBS could provide ways to improve how these disorders are managed.

graphic file with name JGH3-7-152-g001.jpg

Introduction

Gastrointestinal reflux disease (GERD) and irritable bowel syndrome (IBS) are among the most common diseases in humans. 1 , 2 IBS is a chronic functional disorder of the gastrointestinal system with an increasing trend among the population, in which the prevalence of 9.2–32.5% has been reported among adults. 1 , 3 The disease is characterized by abdominal pain and altered bowel habit, with predominantly constipation (IBS‐C), diarrhea (IBS‐D), or both (IBS‐M). 1 , 4 GERD is the most common disease of the esophagus, whose hallmarks include heartburn and acid regurgitation. 5 Its most crucial complication includes esophagitis and Barrett metaplasia, which occurs in approximately 7–15% of patients and increases the risk of progressing into esophageal adenocarcinoma. 6 , 7

Reflux symptoms persist in almost 75% of patients for at least 10 years, its symptoms in IBS patients being usually chronic. Therefore, it is not surprising that IBS and GERD overlap in clinical presentations. 8 In a systematic review, IBS has been reported in 42% of GERD patients. 9 Furthermore, Some studies have reported that the overlap occurs more among males. 10 Male sex is associated with increased signs of reflux and also a higher occurrence of esophagitis. 11 GERD among male patients appears to have more extreme manifestations marked by erosive esophagitis, ulcer of the esophagus, or strictures. 12 , 13 , 14 The reason why males are more vulnerable to getting GERD and IBS together is not known; therefore, further investigation into the potential cause of this gender difference is warranted.

Recent reports by Asian researchers indicate that IBS prevalence is high and equal to that in Western cultures. 15 , 16 In a study by Massarrat et al., 17 male Iranian pastoral nomads of Turkish descent from the south and industrial workers from the north were compared for the prevalence of IBS. Although the nomads consumed less fruits and vegetables, it was believed that their constant travel was responsible for their lower frequency of constipation than that of Western people. Factory employees' arduous physical labor had the same result. On the other hand, factors such as smoking and alcohol use are more prevalent among the male population in Iran, 18 which can be correlated with both GERD and IBS. 19 , 20

Therefore, in this study, we aimed to evaluate GERD's prevalence among male IBS patients in southern Iran. Also, we sought to evaluate the associated risk factors for GERD among IBS patients.

Methods

Study design

In this cross‐sectional descriptive study, patients being referred to the Moslemin clinic from March 2019 to March 2020 (1 year) with an IBS impression were included. This clinic is located in Muslemin hospital and among the main centers in Shiraz, Iran. This center is among the most visited referral centers in southern Iran and provides primary health care to the whole population. Subjects were recruited in a consecutive manner from among patients who either visited our center based on their initial symptoms or were referred to us from tertiary and other centers for better evaluation or endoscopic examination. Patients were informed of the aim of the study, and written informed consents were obtained from them. In case a patient expressed unwillingness to participate, the next consecutive patient was recruited until the desired sample size was achieved.

The inclusion criteria consisted of male patients aged 18–60 years and a diagnosis of IBS who were willing to participate in our research and understood the study's content and the questionnaire. The exclusion criteria consisted of age under 18 or above 60 years, with underlying esophageal movement disorders such as achalasia, scleroderma, diffuse esophageal spasm, or lower esophageal sphincter hypotension, inflammatory bowel diseases such as Crohn's and ulcerative colitis, electrolyte disorders, esophageal diverticulum, cancer of the upper gastrointestinal system, esophageal varices, history of intestinal obstruction or gastrointestinal surgery, or any contraindications regarding endoscopy such as severe cardiovascular diseases or respiratory distress.

Disease diagnosis

For IBS diagnosis, we used the ROME IV criteria, including abdominal pain or discomfort for 12 or more weeks in the past year, although not necessarily consistent, which fulfilled at least two of the three criteria of “Relieved with defecation,” and/or “Onset associated with a change in stool frequency,” and/or “Onset associated with a change in form (appearance) of stool.” Additionally, the GERD hallmark includes heartburn and acid regurgitation based on GERQ. 21

After diagnosing IBS by a single specialized physician, the patients were included in our study and evaluated for GERD features; then, demographic information of the patients such as age, sex, BMI, and GERD features was collected.

Statistical analysis

The sample size was calculated based on a study by Lovell and Ford, by reporting a prevalence of GERD in IBS as 42.0% and considering α = 0.05 and confidence level = 80%; a final sample size of 158 patients was arrived at. 9 The extracted data were analyzed using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA). The data were presented either as descriptive or based on a chi‐square test for evaluating categorical data. Also, statistically significant variables were included in the multivariable logistic regression analysis to adjust for confounding factors. A P‐value <0.05 was considered significant association.

Ethical approval

The study was approved by the Research Ethics Committees of Islamic Azad University‐ Kazerun Branch (Ethical code: IR.IAU.KAU.REC.1399.020) and conducted in compliance with the relevant guidelines and regulations and the Declaration of Helsinki. Written informed consent was obtained from all patients to participate in this study. Patients were free to leave the study at any time. Also, the confidentiality of the patient information was ensured by the researcher.

Results

In the present study, 163 male patients diagnosed with IBS were enrolled for 1 year. All patients entered the study voluntarily. The participants' age ranged from 18 to 60 years (mean age: 31.53; SD: 9.38). Among the patients, 64 (39.3%) were diagnosed with GERD. Table 1 shows the characteristics of the patients in our study and their association with GERD. Based on the patients′ social history, 23/64 (35.9%) patients with GERD were smokers and 12/64 (18.8%) were alcohol users.

Table 1.

Demographic and clinical features of male patients with irritable bowel syndrome and its association with gastrointestinal reflux disease in southern Iran

GERD
Variable Total Yes, n = 64 No, n = 99 P‐value
Mean age ± SD 31.53 ± 9.38 29.82 ± 9.7 32.64 ± 9.05 0.006*
Age group (%)
<30 92 (56.4) 43 (46.7) 49 (53.3) 0.076
30–39 40 (24.5) 9 (22.5) 31 (77.5)
40–49 21 (12.9) 8 (38.1) 13 (61.9)
≥50 10 (6.1) 4 (40) 6 (60)
Average BMI ± SD 25.05 ± 3.52 25.16 ± 3.24 24.97 ± 3.7 0.531
BMI group (%)
<25 99 (60.7) 37 (37.4) 62 (62.6) 0.539
≥25 64 (39.3) 27 (42.2) 37 (57.8)
Social history (%)
Smoking 41 (25.2) 23 (56.1) 18 (43.9) 0.011*
Alcohol 20 (12.3) 12 (60) 8 (40) 0.043*
Type of IBS (%)
Mixed 45 (27.6) 30 (66.7) 15 (33.3) <0.001*
Diarrhea 67 (41.1) 13 (19.4) 54 (80.6)
Constipation 51 (31.3) 21 (41.2) 30 (58.8)
*

Indicates significant association.

BMI, body mass index; GERD, gastrointestinal reflux disease; IBS, irritable bowel syndrome; SD, standard deviation.

On the basis of statistical analysis, there was a significant association between age and incidence of GERD among IBS patients in our study (P = 0.006). Although no significant association was found among the age groups and GERD (P = 0.058), by classifying the patients based on <30 years versus ≥30, a significant association was found, with patients <30 years having a higher incidence of GERD than patients ≥30 years (67.2% vs 32.8%, P = 0.035). Figure S1, Supporting information shows the incidence of GERD based on age and BMI groups, social history, and type of IBS.

Based on our results, there was no significant association between the incidence of GERD among IBS patients and BMI or BMI groups (P > 0.05). Based on the patients′ social history, a significant and higher association was observed between GERD in IBS patients and smoking (P = 0.011) and alcohol consumption (P = 0.043).

Also, GERD among IBS patients was significantly associated with the type of IBS (P < 0.001), with IBS‐D having the lowest incidence (19.4%) and IBS‐M the highest incidence of GERD (66.7%).

Additionally, we performed multivariate analysis to obtain the confounding factors related to the incidence of GERD among IBS patients; the results are reported in Table 2. As can be seen, although age had a reverse correlation with higher prevalence of GERD, there was no statistical significance (OR: –0.030; P = 0.171). However, smoking had a direct and significant correlation with lower incidence of GERD (OR = −1.364; P = 0.002). It is also seen that the type of IBS has a significant association with GERD, with type M having a lower correlation compared to type D but a higher correlation compared to type C (Table 2).

Table 2.

Multivariate regression analysis of risk factors for gastrointestinal reflux disease among male patients with inflammatory bowel syndrome (N = 163)

Variable OR; 95% CI P‐value*
Higher age −0.028 (0.931–1.014) 0.194
Higher BMI 0.041 (0.936–1.159) 0.452
IBS type
M (ref.) <0.001
D 1.054 (1.183–6.953) 0.020
C –1.265 (0.112–0.714) 0.008
Smoker (positive/negative) –1.361 (0.106–0.619) 0.002
Alcohol use (positive/negative) –0.684 (0.168–1.515) 0.223
*

Values in bold indicate significant correlation.

IBS types are compared to the reference variable (Type M).

BMI, body mass index; CI, confidence interval; OR, odds ratio.

Discussion

IBS and its comorbidities have recently been the subject of comprehensive study. However, the exact pathogenesis of GERD and IBS is still unknown, and many surveys have suggested the increased prevalence of GERD in IBS and vice versa. 8 , 22 , 23 , 24 in this study, we aimed to evaluate the incidence of GERD among IBS patients by limiting it to male population for considering the related risk factors among this group. Our results showed a prevalence of 39.3% GERD among male IBS patients with age <30, smoking, and alcohol consumption as the main risk factors.

Our data are in accordance with those in a review by Nastaskin et al., 25 which reported an overlap of 39% between IBS and GERD. They also noted that the diseases together tend to cover a degree and rate that is greater than their incidence in the population. Furthermore, their data show that if one of the disorders is omitted, the other is less prevalent in the population, which implies a possible causal association. 25

Although most studies have focused on the gender difference between GERD and IBS, IBS and functional GI conditions are more common in women than in men. 26 Female‐to‐male ratios of 2–3:1 were recorded in most of the studies. 27 However, GERD among males appears to have more extreme manifestations. 12 , 13 , 28 , 29 Also, a higher positive association between GERD and IBS was found to exist predominantly in male subjects in previous studies. 10 Among the main reasons, one could name the associated risk factors such as alcohol consumption and smoking, which are more frequent among the males, which have also been demonstrated to be risk factors for GERD based on our results. Increasing public knowledge of such risk factors is essential in controlling the incidence of these diseases.

There are many variations regarding the significance of the variables and GERD–IBS overlap among the studies, which justifies the need for evaluating these variables more deeply and extensively and among different populations. Based on our results, younger participants are more vulnerable to both diseases. This finding is similar to that of a study by Cheung et al. 10 In younger subjects, the prevalence of IBS eventually decreases with age. 30 , 31 However, some studies have shown that increasing age was not associated with IBS–GERD overlap. 32 Studies have reported that smoking is a risk factor for GERD 33 ; however, its role in IBS is still controversial and also subtype‐based. 34 , 35 However, some studies have failed to find any significant association between behavioral factors, such as smoking or alcohol consumption, and IBS–GERD overlap. 32 However, studies have also reported that functional heartburn has more overlap with IBS than GERD. Since we could not distinguish true GERD from other functional gastrointestinal disorders without a gold standard test, further studies with a more accurate focus in this regard is necessary. 19

GERD–IBS overlap was significantly lower among IBS‐D patients (19.4%), while IBS‐M patients had the highest GERD incidence (66.7%). IBS‐M type patients are more frequent in our study population, which is in line with previous reports. 4 In a study by Talley et al., 36 overlap with GERD‐related symptoms was found in 32.9% of patients with predominant IBS‐C and 40.9% of patients with predominant IBS‐D. The exact mechanism for this association is still not clear; however, IBS‐C is associated with a higher frequency of bloating and early satiety, which possibly represents fundamental pathophysiological pathways distinct from those in IBS‐D. 36 Brain–gut interaction dysregulation has been proposed as a vital factor in the pathogenesis of IBS. 37 Especially, IBS‐D has been related with autonomic nervous dysfunction but independent of psychological disturbance. 37 However, the exact mechanism involved in the overlap of GERD and the subtypes of IBS is still unclear and warrants further investigations.

Based on our results, there was no significant association between BMI and the overlap of GERD and IBS. Our data contrasts with those of a study by Jung et al. 32 reporting that in only IBS but not GERD was a higher BMI a predictor of increasing IBS–GERD overlap. BMI has also been reported a risk factor for GERD, 38 , 39 while its role in IBS is controversial. 40 Increased somatization relative to GERD alone was another independent risk factor for the IBS–GERD overlap.

There is evidence that social stressors may promote gastroesophageal reflux and IBS, and somatization can be a marker of these conditions. 41 , 42 Psychological disorders such as anxiety and depression have been reported to influence these two conditions. In a study by Rathi et al. 41 among 100 GERD cases, 56 were found to have psychiatric morbidity in the form of either anxiety or depression, which was not associated with the patients′ demographic and social factors. Dissatisfaction with the body image has been reported to influence depression in GERD. 43 A study in China found higher anxiety and depression scores in non‐erosive reflux disease compared to reflux esophagitis. 44 This could indicate that patients with reflux esophagitis are generally less sensitive to pain due to mucosal changes or that patients with non‐erosive reflux disease may perceive GERD symptoms more strongly due to their anxiety or depression. To fully understand this difference, the literature on reliable physiological studies must be examined, but there is strong support for the hypothesis that acid reflux and psychosocial stress are responsible for the higher prevalence of depression and anxiety in these patients. 41

Among the limitations of our study is that we included only male patients. We hypothesized that, since biological markers, mental factors (such as stress and anxiety levels), and also social settings and behavioral pattern differences among the male and female population in Iran could not be evaluated in detail in our study, which could each effect the prevalence and incidence of the disease; 45 , 46 , 47 , 48 , 49 , 50 Therefore, we limited our evaluation to the population more prone to social behavioral distortions, such as smoking and alcohol use, that is, the male population in Iran. Although our method and design may not be flawless, we hoped to achieve a better understanding of the possible risk and concurrent factors among this targeted population. Another factor was that ours was a single‐center study in a referral center in southwest Iran, which limited the study population diversity; however, there was no selection bias and the population was not skewed. We also included patients above 18 and below 60 years of age because there have been reports showing that the symptoms start before 35 years of age, while almost all report symptom onset before they are 50. 51 However, other demographic data were not included in our study, which should be highlighted in future evaluations and studies. Also, detailed symptom evaluation was not performed while GERD was diagnosed based on the GERQ and patient symptoms, while the gold standard, ambulatory 24‐h pH monitoring, was not performed because of limited resources and the design of our study, especially to distinguish between GERD and FGIDs (reflux hypersensitivity and functional heartburn). Ultimately, further multicenter and population‐based studies are required to reach a final conclusion regarding the concurrence of these two diseases.

Conclusion

Our results show that among male IBS patients, younger age, smoking, and alcohol use are among the risk factors for GERD. These findings may provide further insight into the best approach for treating these diseases; however, further multicenter international studies are required.

Supporting information

Figure S1. Distribution of the incidence of gastrointestinal reflux disease (GERD) among male patients with inflammatory bowel syndrome (IBS).

Declaration of conflict of interest: None.

References

  • 1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta‐analysis. Lancet Gastroenterol. Hepatol. 2020; 5: 908–17. [DOI] [PubMed] [Google Scholar]
  • 2. El‐Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro‐oesophageal reflux disease: a systematic review. Gut. 2014; 63: 871–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome‐type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta‐analysis. Lancet Gastroenterol. Hepatol. 2020; 5: 1053–62. [DOI] [PubMed] [Google Scholar]
  • 4. Keshteli AH, Dehestani B, Daghaghzadeh H, Adibi P. Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults. Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 2015; 28: 253–8. [PMC free article] [PubMed] [Google Scholar]
  • 5. Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol. Motil. 2015; 27: 1202–13. [DOI] [PubMed] [Google Scholar]
  • 6. Marques de Sa I, Marcos P, Sharma P, Dinis‐Ribeiro M. The global prevalence of Barrett's esophagus: a systematic review of the published literature. United European Gastroenterol. J. 2020; 8: 1086–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Schlottmann F, Molena D, Patti MG. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma. Updates Surg. 2018; 70: 339–42. [DOI] [PubMed] [Google Scholar]
  • 8. de Bortoli N, Tolone S, Frazzoni M et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann. Gastroenterol. 2018; 31: 639–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Lovell RM, Ford AC. Prevalence of gastro‐esophageal reflux‐type symptoms in individuals with irritable bowel syndrome in the community: a meta‐analysis. Am. J. Gastroenterol. 2012; 107: 1793–801; quiz 1802. [DOI] [PubMed] [Google Scholar]
  • 10. Cheung TK, Lam KF, Hu WH et al. Positive association between gastro‐oesophageal reflux disease and irritable bowel syndrome in a Chinese population. Aliment. Pharmacol. Ther. 2007; 25: 1099–104. [DOI] [PubMed] [Google Scholar]
  • 11. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin. Gastroenterol. Hepatol. 2006; 4: 398–407. [DOI] [PubMed] [Google Scholar]
  • 12. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig. Dis. Sci. 2004; 49: 237–42. [DOI] [PubMed] [Google Scholar]
  • 13. Rosaida MS, Goh KL. Gastro‐oesophageal reflux disease, reflux oesophagitis and non‐erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur. J. Gastroenterol. Hepatol. 2004; 16: 495–501. [DOI] [PubMed] [Google Scholar]
  • 14. Fass R. GERD/dyspepsia. Philadelphia: Hanley & Belfus Inc., 2004. [Google Scholar]
  • 15. Gwee KA, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology, and management. J. Gastroenterol. Hepatol. 2018; 33: 99–110. [DOI] [PubMed] [Google Scholar]
  • 16. Chuah KH, Mahadeva S. The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia. JGH Open. 2021; 5: 1225–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Massarrat S, Saberi‐Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur. J. Gastroenterol. Hepatol. 1995; 7: 427–33. [PubMed] [Google Scholar]
  • 18. Mohammadkhani S. Prevalence of cigarette smoking, alcohol drinking and illegal drugs use among Iranian adolescents. 2012.
  • 19. De Bortoli N, Frazzoni L, Savarino EV et al. Functional heartburn overlaps with irritable bowel syndrome more often than GERD. Am. J. Gastroenterol. 2016; 111: 1711–7. [DOI] [PubMed] [Google Scholar]
  • 20. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population‐based study. Digestion. 2009; 79: 196–201. [DOI] [PubMed] [Google Scholar]
  • 21. Naseri MS, Raz JH, Habibi R, et al. Reliability, validity, and feasibility of the Mayo Gastro‐Esophageal Reflux Questionnaire (GERQ) in a Persian‐speaking population. 2008.
  • 22. Neumann H, Monkemuller K, Kandulski A, Malfertheiner P. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig. Dis. 2008; 26: 243–7. [DOI] [PubMed] [Google Scholar]
  • 23. Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)—is it one disease or an overlap of two disorders? Dig. Dis. Sci. 2009; 54: 1829–34. [DOI] [PubMed] [Google Scholar]
  • 24. Pourhoseingholi A, Vahedi M, Pourhoseingholi MA et al. Irritable bowel syndrome, gastro‐oesophageal reflux disease and dyspepsia: overlap analysis using loglinear models. Arab. J. Gastroenterol. 2012; 13: 20–3. [DOI] [PubMed] [Google Scholar]
  • 25. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig. Dis. Sci. 2006; 51: 2113–20. [DOI] [PubMed] [Google Scholar]
  • 26. Chang L, Toner BB, Fukudo S et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology. 2006; 130: 1435–46. [DOI] [PubMed] [Google Scholar]
  • 27. Yaseri HF. Gender is a risk factor in patients with gastroesophageal reflux disease. Med. J. Islam Repub. Iran. 2017; 31: 58–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018; 154: 267–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease. J. Neurogastroenterol. Motil. 2016; 22: 575–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Choung RS, Locke GR 3rd. Epidemiology of IBS. Gastroenterol. Clin. North Am. 2011; 40: 1–10. [DOI] [PubMed] [Google Scholar]
  • 31. Whitehead WE, Drossman DA. Validation of symptom‐based diagnostic criteria for irritable bowel syndrome: a critical review. Am. J. Gastroenterol. 2010; 105: 814–20; quiz 813, 821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Jung HK, Halder S, McNally M et al. Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment. Pharmacol. Ther. 2007; 26: 453–61. [DOI] [PubMed] [Google Scholar]
  • 33. Etemadi A, Gandomkar A, Freedman ND et al. The association between waterpipe smoking and gastroesophageal reflux disease. Int. J. Epidemiol. 2017; 46: 1968–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Talley NJ, Powell N, Walker MM et al. Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population‐based studies. Aliment. Pharmacol. Ther. 2021; 54: 32–42. [DOI] [PubMed] [Google Scholar]
  • 35. Sirri L, Grandi S, Tossani E. Smoking in irritable bowel syndrome: a systematic review. J. Dual Diagn. 2017; 13: 184–200. [DOI] [PubMed] [Google Scholar]
  • 36. Talley NJ, Dennis EH, Schettler‐Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am. J. Gastroenterol. 2003; 98: 2454–9. [DOI] [PubMed] [Google Scholar]
  • 37. American Gastroenterology Association . American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology. 2002; 123: 2105–7. [DOI] [PubMed] [Google Scholar]
  • 38. Valezi AC, Herbella FAM, Schlottmann F, Patti MG. Gastroesophageal reflux disease in obese patients. J. Laparoendosc. Adv. Surg. Tech. A. 2018; 28: 949–52. [DOI] [PubMed] [Google Scholar]
  • 39. Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016; 159: 475–86. [DOI] [PubMed] [Google Scholar]
  • 40. Emerenziani S, Guarino MPL, Trillo Asensio LM et al. Role of overweight and obesity in gastrointestinal disease. Nutrients. 2019; 12: 111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Rathi P, Gill A, Vankar GK, Ohri N, Patel A. Study of depression and anxiety in endoscopically diagnosed cases of gastro‐oesophageal reflux disease (GERD). Indian J. Mental Health. 2018; 5: 15–28. [Google Scholar]
  • 42. Sibelli A, Chalder T, Everitt H, Workman P, Windgassen S, Moss‐Morris R. A systematic review with meta‐analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol. Med. 2016; 46: 3065–80. [DOI] [PubMed] [Google Scholar]
  • 43. Richard A, Rohrmann S, Lohse T, Eichholzer M. Is body weight dissatisfaction a predictor of depression independent of body mass index, sex and age? Results of a cross‐sectional study. BMC Public Health. 2016; 16: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Yang X‐J, Jiang H‐M, Hou X‐H, Song J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol: WJG. 2015; 21: 4302–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Bigler RS, Hayes AR, Liben LS. Analysis and evaluation of the rationales for single‐sex schooling. Adv. Child Dev. Behav. 2014; 47: 225–60. [DOI] [PubMed] [Google Scholar]
  • 46. Parvar SY, Ghamari N, Pezeshkian F, Shahriarirad R. Prevalence of anxiety, depression, stress, and perceived stress and their relation with resilience during the COVID‐19 pandemic, a cross‐sectional study. Health Sci. Rep. 2022; 5: e460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Rezazadeh F, Farahmand F, Hosseinpour H, Shahriarirad R, Sabet Eghlidi A. The association between emotional stress, sleep disturbance, depression, and burning mouth syndrome. Biomed. Res. Int. 2021; 2021: 5555316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Shahriarirad R, Erfani A, Ranjbar K, Bazrafshan A, Mirahmadizadeh A. The mental health impact of COVID‐19 outbreak: a Nationwide Survey in Iran. Int. J. Ment. Health Syst. 2021; 15: 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Taghizadeh H, Shahriarirad R, Erfani A et al. Seroepidemiological survey of toxoplasmosis among female university students in Shiraz, southern Iran. Ann. Trop. Med. Public Health. 2017; 10: 362. [Google Scholar]
  • 50. McGregor AJ, Hasnain M, Sandberg K, Morrison MF, Berlin M, Trott J. How to study the impact of sex and gender in medical research: a review of resources. Biol. Sex Differ. 2016; 7: 61–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Saberi‐Firoozi M, Khademolhosseini F, Yousefi M, Mehrabani D, Zare N, Heydari ST. Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran. World J. Gastroenterol. 2007; 13: 5486–91. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1. Distribution of the incidence of gastrointestinal reflux disease (GERD) among male patients with inflammatory bowel syndrome (IBS).


Articles from JGH Open: An Open Access Journal of Gastroenterology and Hepatology are provided here courtesy of Wiley

RESOURCES